Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca establishes Scientific Review Board to support clinical trial data transparency commitment
-
AstraZeneca announces positive Phase III top-line results for PT003 from PINNACLE 1 and PINNACLE 2 studies in COPD
-
PEGASUS-TIMI 54 study shows that long-term treatment with BRILINTA reduced thrombotic cardiovascular events in patients with a history of heart attack
-
AstraZeneca to collaborate with key Singapore research organisations in heart failure
-
AstraZeneca to participate in US FDA Endocrinologic and Metabolic Drugs Advisory Committee
-
AstraZeneca completes acquisition of rights to Actavis’ branded respiratory portfolio in the US and Canada
-
AstraZeneca and Cambridge Judge Business School announce collaboration to identify and support biotech start-ups
-
AstraZeneca to create stand-alone company for small molecule early-stage antibiotic R&D
-
AstraZeneca and Orca Pharmaceuticals announce research collaboration to identify best-in-class RORγ inhibitors to treat auto-immune diseases
-
AstraZeneca announces Non-Executive Board changes
Latest articles and press releases
All of our latest press releases and articles are available to explore
